Evaluating the CALLY Index for Predicting Delirium After Hip Surgery in Older Patients
Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergoing Hip Fracture Surgery
This study is testing if a new index can help predict delirium in older patients after they have hip surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Ankara Ataturk Sanatorium Training and Research Hospital Government |
| Locations | 1 site (Ankara, Keçiören) |
| Trial ID | NCT06818409 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effectiveness of the CRP-Albumin-Lymphocyte (CALLY) Index in predicting postoperative delirium (POD) in geriatric patients undergoing hip fracture surgery. It focuses on patients aged 65 and older, monitoring various biomarkers associated with delirium. The study will utilize the DSM-5 criteria for diagnosing delirium and will screen patients daily for signs of POD following their surgical procedures. The findings could help identify at-risk patients and improve postoperative care.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 65 years and older who are scheduled for surgery due to femoral neck or intertrochanteric fractures.
Not a fit: Patients with preoperative delirium, dementia, or other significant comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better prediction and management of postoperative delirium, potentially reducing hospital stays and improving outcomes for elderly patients.
How similar studies have performed: While the approach of using biomarkers for predicting POD is gaining interest, the specific use of the CALLY Index in this context is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 65 years and older who undergo surgery for femoral neck or intertrochanteric fractures Exclusion Criteria: * Patients with preoperative delirium * Patients with preoperative dementia * Patients with pathological fractures * Patients with open fractures * Patients with systemic or localized infections in the fracture region during the preoperative period * Patients with multiple trauma * Patients with a BMI \<18.5 or ≥35 * Patients with chronic organ failure * Patients with advanced-stage cancer
Where this trial is running
Ankara, Keçiören
- University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital — Ankara, Keçiören, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Erbil Türksal, Specialist — University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital
- Study coordinator: ERBİL TÜRKSAL, Specialist
- Email: drerbilturksal@hotmail.com
- Phone: 530 228 1319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.